Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- Industry Associations Call for Delay in Ratification of COP10 Nagoya Protocol
October 10, 2014
- US Nonprofit ACRES Launches Japan Branch
October 8, 2014
- National University Hospital Council’s Guidelines Not to Require Disclosure of Individuals’ Names
October 7, 2014
- JPMA Plans Disclosure of Recipients, Amount of Payments for R&D Outlays
October 3, 2014
- Bayer Yakuhin President to Become New EFPIA Japan Chairman
October 2, 2014
- JPMA Weighs Disclosure of Ad Payments to Commercial Medical Publishers
September 26, 2014
- JPMA to Unify Method of Disclosing Sensitive Payment Information from Next Year
September 22, 2014
- JPMA to Suspend Hasegawa’s Veep Activities for Another 6 Months over CASE-J
September 19, 2014
- CDISC CEO Advises Drug Makers to Collect Data Based on CDASH
August 27, 2014
- NEDO, NCC, Toray to Jointly Develop Simple Test Systems for Cancers and Dementia
August 20, 2014
- Fair Discussions Necessary for Full Introduction of New Drug Development Premium: Chuikyo Member
August 12, 2014
- Drug Price Settlement Rate Will Rise towards Sept.: JPWA Chief
August 11, 2014
- OTC Drug Federation Requests Ministry to Advance Prescription-to-OTC Switches
July 31, 2014
- Generic Drugs See 45.1% Market Share in FY2013 in New Calculation
July 29, 2014
- JPMA President Hints at Adoption of Unified System to Disclose Fees Paid to Doctors Next Year
July 25, 2014
- Kampo Manufacturers Group Names Tsumura President as New Chairman
July 24, 2014
- Number of Drug Reps Rebounds to 65,752 in FY2013, Buoyed by Major Product Debuts
July 23, 2014
- Medwatcher Elbows Expert Group to Disclose Financial Links with HPV Vaccine Makers
July 22, 2014
- Generic Switch Saved 22.7 Billion Yen in Drug Costs over 5 Years: Kyokai Kenpo
July 17, 2014
- JGA to Use Independent Organizations to Conduct GMP Inspections of Overseas Drug Substance Production Facilities
July 17, 2014
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…